| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |